Prof Declan Murphy
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
810 Scholarly works
9 Projects
HIGHLIGHTS
2026
Journal article
Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma
DOI: 10.1038/s41467-026-74255-x2026
Journal article
Management of De Novo miN1 Prostate Cancer in the PSMA-PET Era
DOI: 10.1002/pros.702312026
Research grants (ARC, NHMRC, MRFF)
Unraveling Metastasis-Specific Immune Niches to Transform Cancer Treatment
2019
Research Grant
Up-Front Psma Alliance: Using Theranostics Early to Eradicate Prostate Cancer and Developing Novel Startegies for Psma-Negative Disease
2018
Journal article
Cold kit for prostate-Specific membrane antigen (PSMA) PET imaging: Phase 1 study of 68Ga-Tris (Hydroxypyridinone)-PSMA PET/CT in patients with prostate cancer
DOI: 10.2967/jnumed.117.1995542017
Conference Proceedings
Lutetium-177 PSMA (LuPSMA) theranostics phase II trial: Efficacy, safety and QoL in patients with castrate-resistant prostate cancer treated with LuPSMA
DOI: 10.1093/annonc/mdx370.0022017
Research Grant
Biofocussed Prostate Cancer Radiotherapy (Birt): A Personalised Approach to Delivering the Right Dose to the Right Place
RECENT SCHOLARLY WORKS
2026
Conference Proceedings
DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysis
DOI: 10.1038/s41391-025-01047-72026
Journal article
Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancer
DOI: 10.1111/bju.702832026
Journal article
Effect of the November 2023 Medicare Benefits Schedule PSA Testing Reform on National Utilisation, Diagnostic Activity, and Health-System Expenditure in Australia
DOI: 10.3390/siuj70400582026
Journal article
Darolutamide With Concomitant Lipid-Modifying Agents in Nonmetastatic Castration-Resistant Prostate Cancer
DOI: 10.1001/jamanetworkopen.2026.299362026
Journal article
First Images on a Next-Generation Extended-Field-of-View Digital Bismuth Germanium Oxide Total-Body PET/CT
DOI: 10.2967/jnumed.125.2719952026
Journal article
Guideline of guidelines: pelvic lymph node dissection at time of radical prostatectomy
DOI: 10.1111/bju.702772026
Journal article
Long-term trends in androgen-directed therapy in advanced prostate cancer: a 29-year national analysis
DOI: 10.1007/s11255-026-05003-92026
Journal article
End of the TRUS era: transperineal biopsy takes the lead in prostate cancer detection
DOI: 10.1038/s41585-025-01090-y